Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; the references it cites are not checked yet.

Current insights into the role of Fli-1 in hematopoiesis and malignant transformation

Open access
Ben-David, Yaacov, Gajendran, Babu, Sample, Klarke M., Zacksenhaus, Eldad · 2022 · Cellular and Molecular Life Sciences

Abstract

Fli-1, a member of the ETS family of transcription factors, was discovered in 1991 through retroviral insertional mutagenesis as a driver of mouse erythroleukemias. In the past 30 years, nearly 2000 papers have defined its biology and impact on normal development and cancer. In the hematopoietic system, Fli-1 controls self-renewal of stem cells and their differentiation into diverse mature blood cells. Fli-1 also controls endothelial survival and vasculogenesis, and high and low levels of Fli-1 are implicated in the auto-immune diseases systemic lupus erythematosus and systemic sclerosis, respectively. In addition, aberrant Fli-1 expression is observed in, and is essential for, the growth of multiple hematological malignancies and solid cancers. Here, we review the historical context and latest research on Fli-1, focusing on its role in hematopoiesis, immune response, and malignant transformation. The importance of identifying Fli-1 modulators (both agonists and antagonists) and their potential clinical applications is discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00018-022-04160-1

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 112 · Cited by 54

Metadata

Authors
Ben-David, Y., Gajendran, B., Sample, K. M., & Zacksenhaus, E.
Affiliations
  • Guiyang Medical University (CN)
  • University Health Network (CA)
Venue
Cellular and Molecular Life Sciences
Published
2022-02-28
Volume
79
Issue
3
Pages
163-163
ISSN
  • 1420-682X (ISSN-L)
  • 1420-9071
OpenAlex
W4223519368
Cited by
54
References
112
Citations by year
2026: 12 · 2025: 15 · 2024: 20 · 2023: 5 · 2022: 2
FWCI
1.91
Type
journal article
Language
en
Open access
Licence
Locations
  • Cellular and Molecular Life Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (U1812403, 21867009)
  • Guizhou Science and Technology Department (QKHPTRC[2019]5627)
Topics
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
Keywords
FLI1, ETS transcription factors, hematopoiesis, hematologic malignancies, malignant transformation, erythroleukemia, hematopoietic stem cell self-renewal, vasculogenesis, systemic lupus erythematosus, systemic sclerosis
MeSH terms
Animals, Cell Differentiation, Cell Transformation, Neoplastic, Leukemia, Erythroblastic, Acute, Hematopoiesis, Mice, Proto-Oncogene Protein c-fli-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current insights into the role of Fli-1 in hematopoiesis and malignant transformation. https://app.cochat.ai/papers/10.1007/s00018-022-04160-1
The paper
Ben-David, Y., Gajendran, B., Sample, K. M., & Zacksenhaus, E. (2022). Current insights into the role of Fli-1 in hematopoiesis and malignant transformation. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-022-04160-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.